SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001493152-24-019933
Filing Date
2024-05-15
Accepted
2024-05-15 16:33:54
Documents
47
Period of Report
2024-03-31

Document Format Files

Seq Description Document Type Size
1 form10-q.htm   iXBRL 10-Q 573801
2 ex31-1.htm EX-31.1 20078
3 ex31-2.htm EX-31.2 20302
4 ex32-1.htm EX-32.1 11397
  Complete submission text file 0001493152-24-019933.txt   3452881

Data Files

Seq Description Document Type Size
5 XBRL SCHEMA FILE ptix-20240331.xsd EX-101.SCH 26899
6 XBRL CALCULATION FILE ptix-20240331_cal.xml EX-101.CAL 33505
7 XBRL DEFINITION FILE ptix-20240331_def.xml EX-101.DEF 146941
8 XBRL LABEL FILE ptix-20240331_lab.xml EX-101.LAB 254421
9 XBRL PRESENTATION FILE ptix-20240331_pre.xml EX-101.PRE 196384
51 EXTRACTED XBRL INSTANCE DOCUMENT form10-q_htm.xml XML 443506
Mailing Address 149 FIFTH AVENUE SUITE 500 NEW YORK NY 10010
Business Address 149 FIFTH AVENUE SUITE 500 NEW YORK NY 10010 (212) 994-8200
Protagenic Therapeutics, Inc.\new (Filer) CIK: 0001022899 (see all company filings)

IRS No.: 061390025 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-12555 | Film No.: 24951820
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)